scp-111
Generic: furosemide·Code: SCP-111
scp-111: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| scPharmaceuticals Inc. (SCPH) | Phase 1 |
Clinical Trials (1)
Open-label, Single-dose, Randomized, Two-way Crossover Study to Compare the Pharmacokinetics and Pharmacodynamics of Subcutaneous Injection of SCP-111 (Furosemide) vs Intravenous Injection of Furosemide in Healthy Volunteers
Frequently asked questions
Who is developing scp-111?
scp-111 is being developed by scPharmaceuticals Inc..
How many clinical trials involve scp-111?
BioSniper tracks 1 clinical trial involving scp-111.
Get deeper analysis on scp-111
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis